Q&As

View Life Sciences by content type:

Latest Life Sciences News

Featured Life Sciences content

Practice notes
A director who is in any way, directly or indirectly, interested in:•a proposed transaction or arrangement with the company of which they are a...
Read More >
9th Nov
Practice notes
In order to establish that an unauthorised use or dealing in a product or process amounts to infringement of a patent it is necessary to prove that:•a...
Read More >
9th Nov
Practice notes
This Practice Note provides an introduction to arbitration and its key features, with a particular focus on arbitration under the law of England and...
Read More >
Produced in partnership with Simmons & Simmons LLP 12th Jan
Practice notes
Brexit: The UK's departure from the EU on exit day, ie Friday 31 January 2020, has implications for practitioners considering applicable law. For...
Read More >
9th Nov
Practice notes
An intellectual property (IP) owner may choose to license its IP to a third party. This can be an effective route to generating revenue while...
Read More >
Produced in partnership with Jessica Stretch 12th Jan
Practice notes
This Practice Note provides an introduction to retained EU law, which is an entirely new legal concept introduced to UK domestic law in preparation...
Read More >
9th Nov
Practice notes
As of exit day (31 January 2020) the UK is no longer an EU Member State. However, in accordance with the Withdrawal Agreement, the UK has entered an...
Read More >
9th Nov
Practice notes
Brexit: The UK's departure from the EU on exit day ie Friday 31 January 2020 has implications for practitioners considering the use of ADR as it may...
Read More >
9th Nov
Practice notes
Introduction to infringementA patent owner has to prove two elements before it can secure an infringement finding (and then an injunction, damages,...
Read More >
9th Nov
Practice notes
As of exit day (31 January 2020) the UK is no longer an EU Member State. However, in accordance with the Withdrawal Agreement, the UK has entered an...
Read More >
9th Nov
Precedents
Option 1—deed executed by a company under its common seal (model articles, where the authorised signatory is an...
Read More >
9th Nov
Precedents
1 Intellectual property rights indemnity 1.1 The Supplier shall defend the Customer against any third party claim that...
Read More >
9th Nov
Practice notes
Brexit: The UK's departure from the EU on exit day, ie Friday 31 January 2020, has implications for practitioners considering applicable law. For...
Read More >
9th Nov
Precedents
Month means a calendar month; Close This is a suggested definition for the term 'month', which...
Read More >
9th Nov

Most recent Q&As content

Q&As
We have assumed that service is pursuant to a notice clause in a commercial contract.Contractual definitionWhere a contract defines what a ‘by hand’...
Read More >
15th Feb
Q&As
Variation of contracts and deedsAn existing contract or deed may be varied in writing, provided that the variation satisfies the usual requirements...
Read More >
15th Feb
Q&As
This Q&A assumes that both the contract with the supplier and the contract with the customer are subject to English law.Breach of contractThere are...
Read More >
Produced in partnership with Lynne Counsell of 9 Stone Buildings 15th Feb
Q&As
This Q&A is referring to execution of a document as a deed on behalf of a company.Requirements for execution of a deed on behalf of a company by...
Read More >
15th Feb
Q&As
We have assumed that the question relates to the execution of a scanned version of a contract or deed.We would like to refer you to the following...
Read More >
15th Feb
Q&As
Early terminationThere are numerous different circumstances that may lead a party to wish to terminate an agreement early (eg for convenience on...
Read More >
15th Feb
Q&As
Under section 1(2) of the Law of Property (Miscellaneous Provisions) Act 1989, a deed must be:•in writing•clear on its face that it is intended to be...
Read More >
Produced in partnership with Hannah Maidment of HRC Law 15th Feb
Q&As
The regulatory framework for e-cigarettes consists of a triumvirate of legislation consisting of Directive 2001/83/EC, (the Pharmaceutical Code) and...
Read More >
13th Feb
Q&As
Article 37(1) of Regulation (EU) 2016/679, the General Data Protection Regulation (GDPR), introduces a requirement that businesses must appoint a Data...
Read More >
13th Feb
Q&As
For guidance on collaborative research and development (R&D) agreements, see Practice Note: Know-how—protection and licensing, which provides guidance...
Read More >
13th Feb
Q&As
A clear separation should be maintained between medical and commercial teams. No sales personnel should ever be involved in the delivery of scientific...
Read More >
13th Feb
Q&As
In the EU, Directive 2001/83/EC (consolidated version 26.07.2019), the Pharmaceutical Code regulates the sale of medicinal products. The...
Read More >
13th Feb
Q&As
All medicinal products in the EU are subject to a strict testing and assessment of their quality, efficacy and safety before being authorised. Once...
Read More >
13th Feb
Q&As
Article 104(3) of Directive 2001/83/EC (consolidated version 26.07.2019), the Pharmaceutical Code establishes the requirement for the marketing...
Read More >
13th Feb
Q&As
For the purposes of this Q&A, we have focused on the scenario where the principal (not necessarily as an employer) has an IPR indemnity clause in its...
Read More >
Produced in partnership with Shobana Iyer of Swan Chambers 13th Feb
Q&As
Any organisation based in the UK which offers medicines for sale to the public in the UK or in another EU/EEA country via a website must be registered...
Read More >
13th Feb
Q&As
The following Practice Notes are useful when considering the current position regarding product liability in the life sciences sector (although the...
Read More >
13th Feb

Popular documents